trending Market Intelligence /marketintelligence/en/news-insights/trending/neJMJX-EmtNQ8eh6XTp1dg2 content esgSubNav
In This List

Cancer Genetics prices $7M direct offering of units

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Cancer Genetics prices $7M direct offering of units

Cancer Genetics Inc. priced its registered direct offering of 3.5 million units at $2 per unit to raise about $7 million in gross proceeds.

Each unit consists of 1 common share and one warrant to buy a single common share at $2.35 per share.

Each warrant will be exercisable six months after issuance and will expire 18 months after issuance.

The offering is expected to close Dec. 12, subject to customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.